The FDA Authorizes First COVID-19 Breathalyzer Test


The Food and Drug Administration (FDA) announced last Thursday that A COVID-19 breathalyzer test with the ability to provide diagnostic results in three minutes has won FDA emergency use authorization. The test, made by Frisco, Texas-based InspectIR Systems, is authorized for those 18 and older and in settings where samples are both collected and analyzed, such as doctor’s offices, hospitals, or mobile testing sites. The device is about the size of a piece of carry-on luggage, the FDA said and works by detecting chemical compounds in breath samples associated with SARS-CoV-2 infection.